Analyst Ratings for MetLife (MET)
MET Rating Summary
MET Price Target Summary
- Highest: $111.00 (Morgan Stanley)
- Lowest: $80.00 (BMO Capital)
- Average: $101.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$101.29 (+7.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$101.29 (+7.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2026 | Evercore ISI » Updated 8/24/2026 |
Thomas Gallagher | Downgrade | In Line (Outperform) |
106.00 (103.00) |
80.32 (94.42) |
17.55% | Details |
| 12/16/2025 | Mizuho » Updated 7/9/2026 |
Yaron Kinar | New Coverage | Outperform (N/A) |
102.00 (95.00) |
82.16 (94.42) |
14.92% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
